A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)
about
Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemiaIntravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsFerrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysisAnemia in inflammatory bowel disease: an under-estimated problem?Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysisIron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group RecommendationsIntravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial.Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemiaManagement of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic ReviewThe Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease.Efficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice.A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease.A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.Management of Iron Deficiency Anemia.Serum matrix metalloproteinase 9 (MMP9) as a biochemical marker for wasting marmoset syndromeComparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in KoreaSerum paraoxonase 1 activity in patients with iron deficiency anemia.A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23.A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemiaEuropean consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases.Anaemia in the Elderly IBD Patient.How we diagnose and treat iron deficiency anemia.Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment.Systematic review and meta-analysis of iron therapy in anaemic adults without chronic kidney disease: updated and abridged Cochrane review.Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease.Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency.Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply.Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies.Iron deficiency beyond erythropoiesis: should we be concerned?[Diagnostic approach to iron deficiency anemia].Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.Letter: inconsistency in reporting of hypophosphataemia after intravenous iron-authors' reply.Letter: inconsistency in reporting of hypophosphatemia after intravenous iron.Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease.Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions.Intravenous Irons: From Basic Science to Clinical PracticeThe biocompatibility evaluation of iron oxide nanoparticles synthesized by a one pot process for intravenous iron supply
P2860
Q26750413-8CA4414E-DCA5-451B-A6E9-CF0810B9073CQ26772074-D5284364-CA4F-4700-8F98-813AAB7C9E24Q26822051-A9D18DD6-3BAF-461B-B47D-A4FE16B0E0CDQ26860882-8F4784E2-CD97-401F-A234-B6A86BE08983Q28082489-4EC48C87-83B2-47FD-BA7A-1CE1982FB88EQ28088503-156E20F8-B222-48D8-B750-0B027CACE59CQ34466623-FD6E66E9-3657-4581-99DA-663E7E66D508Q35078212-07EE4A45-EE5A-4FC2-8336-76F3F2D0C77EQ35594086-872B4473-ABF5-4943-8CC2-D973420AEBC9Q35659768-81B6A9DC-30FB-4C55-830C-5B291EB0ADD8Q35738490-ACCC830C-1F9A-484F-B49D-E336CF0E3568Q35864436-6D4AC07F-967E-4550-ADD2-138D94FD33A3Q36357208-F1C045EC-B667-4A2B-B7C4-67E59C110426Q36722337-31A1C6E9-612D-45EC-B7A7-5F9AE457A654Q36812538-0EDFEA8F-8002-49C5-9B01-6187349F245FQ36999318-CFB6C8F4-F535-44BD-A0D8-214BF1534E4CQ37066370-18E5303B-F814-40A0-A1D5-990B4B9529D9Q37100478-0449446E-1802-4592-911A-01A89DA2F09FQ37352255-F8EF9EB1-AD4D-4D97-9B48-2DB3F11653B3Q37494947-621ACB1A-2762-4BCA-AC48-6EBD5280BADAQ37717825-17665ED9-70E0-411A-BDF0-0D391C9362A5Q38291941-D5A1D077-C1F7-4E06-99C8-5E32C3DC8A3DQ38545416-2E8DD778-3386-4E07-8977-A2A1393A1AF1Q38593099-11FBCC3B-21A8-41E1-BAF0-BBB686317C2AQ38714322-4B4FA0CC-EB7A-4FF3-AFDD-7196AA8C1756Q38819226-60DF4FBE-9683-475C-9892-66A0D734D12EQ38888208-0753602F-087F-4ED2-BF62-8FD87F71E6CCQ47103693-693DE8F8-0B0F-464F-A6F1-B928C133D51FQ47150789-5CD67BEB-CA50-4E78-A728-D948D691C01CQ47843180-B90E4AC9-AF11-4EAE-BEA8-113D1E51C024Q47843187-423DEEBD-F806-4DB1-A058-654E3A2B27AEQ48011055-DCB64833-7883-402A-AE6A-8C92450CBD0EQ48092481-647647C6-6C25-410E-8583-EDCE6492F52BQ48225857-B83BD456-942C-4A8E-90CB-CBAAAE623527Q48245608-1E98A60F-B08A-444D-B927-4E051ED5CDB6Q48245674-980F8463-EBB5-42B5-8A79-362D97487D00Q54211926-3AA9E271-67F9-4109-B72B-4FC72AE5DAE1Q55089372-D2AD5C9A-037F-40DE-B9BF-8CD4333DFCE6Q57167424-250F9FCA-0884-430B-A069-280FA45C8EDAQ57238642-E728DF6B-DC82-449F-880D-2F557AE5098B
P2860
A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A randomized, open-label, non- ...... ent of anemia in IBD (PROCEED)
@en
A randomized, open-label, non- ...... nt of anemia in IBD (PROCEED).
@nl
type
label
A randomized, open-label, non- ...... ent of anemia in IBD (PROCEED)
@en
A randomized, open-label, non- ...... nt of anemia in IBD (PROCEED).
@nl
prefLabel
A randomized, open-label, non- ...... ent of anemia in IBD (PROCEED)
@en
A randomized, open-label, non- ...... nt of anemia in IBD (PROCEED).
@nl
P2093
P2860
P356
P1476
A randomized, open-label, non- ...... ent of anemia in IBD (PROCEED)
@en
P2093
Andrew V Thillainayagam
Cornelia Gratzer
Istvan Altorjay
Lars L Thomsen
Michael Staun
Rakesh K Tandon
Sandeep Nijhawan
Walter Reinisch
P2860
P2888
P304
P356
10.1038/AJG.2013.335
P407
P577
2013-10-22T00:00:00Z
P5875
P6179
1001784493